Related Experiment Video

Updated: Aug 20, 2026

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

Desensitization of insulin secretion by depolarizing insulin secretagogues

Ingo Rustenbeck1, Antje Wienbergen, Claudia Bleck

  • 1Institute of Pharmacology and Toxicology, University of Braunschweig, Mendelssohnstr. 1, D-38106 Braunschweig, Germany. i.rustenbeck@tu-bs.de

Diabetes
|November 25, 2004
PubMed

Insights

Prolonged stimulation causes beta-cell desensitization, reducing insulin secretion responsiveness. Recovery involves granule replenishment, but beta-cell death is not directly linked to this process.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Metabolic Research

Background:

  • Prolonged stimulation of insulin secretion can lead to a reversible state of decreased responsiveness, known as desensitization.
  • This desensitization can occur rapidly, within an hour of exposure to depolarizing stimuli.
  • Desensitization impacts beta-cells' ability to respond to various stimuli.

Purpose of the Study:

  • To investigate the mechanisms and characteristics of beta-cell desensitization induced by secretagogues.
  • To explore the relationship between desensitization, insulin granule content, and beta-cell function.
  • To determine if depolarization and calcium influx lead to beta-cell death.

Main Methods:

  • Exposure of beta-cells to depolarizing secretagogues (sulfonylureas, imidazolines, quinine).
  • Assessment of secretory responsiveness to nutrient and non-nutrient stimuli.
  • Evaluation of ATP-sensitive K+ channel (KATP channel) activity and Ca2+ handling.
  • Measurement of immunoreactive insulin content and secretory granule levels.
  • In vitro recovery experiments following desensitization.

Main Results:

  • Desensitization shows cross-resistance against other KATP channel-blocking secretagogues.
  • Desensitized beta-cells may not exhibit altered KATP channel activity or Ca2+ handling.
  • Reduced insulin content and secretory granules accompany desensitization.
  • Recovery from desensitization involves partial reversal of granule depletion and affects granule biogenesis and exocytosis.
  • No direct correlation was found between granule content and secretory responsiveness.

Conclusions:

  • Beta-cell desensitization is a complex process affecting insulin secretion and granule dynamics.
  • While recovery involves granule replenishment, it doesn't directly restore full secretory responsiveness immediately.
  • Depolarization and Ca2+ influx do not appear to directly cause apoptotic or necrotic beta-cell death.

More Related Videos

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate05:58

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on: June 25, 2019

Coculture Analysis of Extracellular Protein Interactions Affecting Insulin Secretion by Pancreatic Beta Cells05:51

Coculture Analysis of Extracellular Protein Interactions Affecting Insulin Secretion by Pancreatic Beta Cells

Published on: June 15, 2013

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...